ABC294640
102418
Phase 2 small_molecule terminated
Quick answer
ABC294640 for Carcinoma, Hepatocellular is a Phase 2 program (small_molecule) at Apogee Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Apogee Therapeutics
- Indication
- Carcinoma, Hepatocellular
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated